Improved method of engineering T-cells to attack cancer
Researchers at Cardiff University have found a way to boost the cancer-destroying ability of the immune system's T-cells, offering new hope in the fight against...
Researchers at Cardiff University have found a way to boost the cancer-destroying ability of the immune system's T-cells, offering new hope in the fight against...
The issue was guest edited by Ron Allison (The Brody School of Medicine, USA) who stated: "Imagine a tumor lighting up for the surgeon to...
The Prostate Health Index (phi) is a cost-effective tool used by urologists to detect prostate cancer. It reduces the risk of over diagnosis, and cuts...
LUGANO, 20 November 2017 - A randomised trial in 650 patients has confirmed the safety and efficacy of a new second line treatment for metastatic...
LUGANO, 20 November 2017 - Osimertinib improves progression-free survival compared to standard first line therapy in Asian patients with EGFR-mutated non-small-cell lung cancer (NSCLC), according...
Credit: CeMM/ Abdelghani Mazouzi (Vienna, Nov. 17, 2017) The destructive force of UV radiation on DNA molecules is only fully visible, when repair mechanisms fail:...
Credit: © European Society for Medical Oncology LUGANO, Switzerland - The European Society for Medical Oncology (ESMO) opened its 3rd ESMO Asia Congress today, once...
CHICAGO - Women with higher body mass index (BMI) face an increased risk of not detecting their breast tumor until it has become large, according...
CAMBRIDGE, MA - Doctors have many drugs available to treat multiple myeloma, a type of blood cancer. However, there is no way to predict, by...
WASHINGTON -- Drugs designed to halt cancer growth may offer a new way to control high blood pressure (hypertension), say Georgetown University Medical Center investigators....
A recent study showed approximately one-fifth of patients with cancer experienced post-traumatic stress disorder (PTSD) several months after diagnosis, and many of these patients continued...
Credit: Phil Jones, Senior Photographer, Augusta University AUGUSTA, Ga. (Nov. 20, 2017) - A national cooperative group trial is making a handful of the country's...
ANN ARBOR, Michigan -- The immune cells that are trained to fight off the body's invaders can become defective. It's what allows cancer to develop....
A subanalysis of the phase III ALEX study has shown that alectinib (1) 600 mg twice daily is more effective than standard of care crizotinib...
LUGANO, 17 November 2017 - Researchers have explored the analysis of mutations in cerebrospinal fluid of lung cancer patients with brain metastases in a study...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.